Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

2026 will see modest growth and selective mega deals — Interview with Matthew Edwards, Osborne Clarke

Healthcare and life sciences deal activity is expected to pick up in 2026, following trends seen in 2025 when the market remained steady despite regulatory challenges, according to a recent report from global law firm Osborne Clarke. HBI spoke to Matthew Edwards, Partner at Osborne Clarke, to explore these developments and what they could mean for healthcare and life sciences transactions in 2026.
February 26, 2026

Novartis sells Indian arm to PE as big pharma pivots to specialty medicines

Global pharma is increasingly viewing emerging markets in three segments, retaining operations hubs and premium specialty markets while exiting older, mass‑market generics. European companies are divesting legacy portfolios to focus on high-growth biologics and precision medicines.
February 26, 2026

Australian CRO SSR invests in Singapore’s Expecto Health Science 

Southern Star Research (SSR), an Australian clinical research organisation (CRO) backed by private equity firm Quadrant, has invested growth capital in Singapore-headquartered CRO Expecto Health Science. With this investment, the two CROs will form a strategic partnership to facilitate transition for sponsors from early-phase studies in Australia and New Zealand into late-phase clinical development across key Asian markets. 
February 26, 2026

Sovereign Capital Partners buys Apollo Home Healthcare

Sovereign Capital Partners, a UK private equity firm, has acquired healthcare-at-home service provider Apollo Home Healthcare. Apollo is a primary provider of nurse-led complex care at home for individuals eligible for NHS Continuing Healthcare (CHC) funding. It provides personalised high-acuity care, with a focus on children and adults with complex clinical needs, acting as a commissioned provider for the NHS to deliver care packages that are fully funded by the health service.
February 26, 2026

PMI growth is much higher in emerging markets

We've published our first ever Special Report on the private medical insurance (PMI) industry this week. The report includes a section on the huge PMI opportunity in emerging markets. Emerging market countries tend to have less comprehensive public or social health coverage and rely much more on out of pocket spending. They also tend to have faster growth both in their overall economies and in the proportion of their GDP that goes towards healthcare. 
February 25, 2026
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us